Trial Details
UNKNOWNBasic Information
| Clinical ID | c2008 |
|---|---|
| Identifier | NCT04122586 |
| Trial Title | Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role Metabolism Ingredients of Tongxieyaofang |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBS (Irritable Bowel Syndrome) |
| Interventions | DRUG: Tongxieyaofang(granule) |
Participant Information
| Sponsor | Xiyuan Hospital of China Academy of Chinese Medical Sciences |
|---|---|
| City | Beijing Municipality |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2018-08-01 |
|---|---|
| Primary Completion Date | 2020-12-31 |
| Completion Date | 2021-12-31 |